Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:3042-3048
Published online before print August 7, 2008, doi: 10.1161/STROKEAHA.108.521898
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/11/3042    most recent
STROKEAHA.108.521898v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, M.
Right arrow Articles by Xiong, Z.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, M.
Right arrow Articles by Xiong, Z.-Q.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Other Stroke Treatment - Medical

(Stroke. 2008;39:3042.)
© 2008 American Heart Association, Inc.


Original Contributions

Differential Roles of NMDA Receptor Subtypes in Ischemic Neuronal Cell Death and Ischemic Tolerance

Min Chen, MD; Ting-Jia Lu, BS; Xiao-Jing Chen, BS; Yang Zhou, PhD; Qian Chen, PhD; Xiao-Yan Feng, BS; Li Xu, MS; Wen-Hu Duan, PhD Zhi-Qi Xiong, PhD

From the Institute of Neuroscience (M.C., T.-J.L., X.-J.C., Y.Z., Q.C., X.-Y.F., L.X., Z.-Q.X.), State Key Laboratory of Neuroscience, Shanghai, China; and the Shanghai Institute of Materia Medica Shanghai Institutes for Biological Sciences (W.-H.D.), Chinese Academy of Sciences, Shanghai, China.

Correspondence to Zhi-Qi Xiong, PhD, 320 Yue Yang Road, Shanghai 200031, China. E-mail xiongzhiqi{at}ion.ac.cn

Background and Purpose— Activation of NMDA subtypes of glutamate receptors is implicated in cell damage induced by ischemia as well as for the establishment of ischemic tolerance after ischemic preconditioning in animal models. We investigated the contributions of NR2A- and NR2B-containing NMDA receptors to ischemic cell death and ischemic tolerance in a rat model of transient global ischemia.

Methods— Transient global ischemia was produced in rats by 4-vessel occlusion. Neuronal injury was analyzed by Fluoro-Jade B and Nissl staining. Phosphorylation of CREB was detected by Western blotting and immunohistochemistry. In situ hybridization and reverse transcriptase-polymerase chain reaction were used to evaluate the mRNA level of cpg15 and bdnf.

Results— NR2A subtype-specific antagonist NVP-AAM077 enhanced neuronal death after transient global ischemia and abolished the induction of ischemic tolerance. In contrast, NR2B subtype-specific antagonist ifenprodil attenuated ischemic cell death and enhanced preconditioning-induced neuroprotection. Furthermore, selectively blocking NR2A-, but not NR2B-, containing NMDA receptors inhibited ischemia-induced phosphorylation of CREB and the subsequent upregulation of CREB target genes such as cpg15 and bdnf.

Conclusions— We found that NR2A- and NR2B-containing NMDA receptor subtypes play differential roles in ischemic neuronal death and ischemic tolerance, suggesting attractive new strategies for the development of drugs for patients with stroke.


Key Words: CREB • ifenprodil • ischemic tolerance • NMDA receptor • NVP-AAM077 • transient global ischemia